| | Approved symbol | Approved name | Activity | Location | Synonym |
| | BCL2 | B-cell CLL/lymphoma 2 | Prosurvival | 18q21.3 | Bcl-2, PPP1R50 | | BCL2L1 | BCL2-like 1 | Prosurvival | 20q11.21 | Bcl-X, bcl-xL, bcl-xS,
BCL2L, BCLX, PPP1R52 | | BCL2L2 | BCL2-like 2 | Prosurvival | 14q11.2-q12 | BCL-W, KIAA0271, PPP1R51 | | MCL1 | Myeloid cell leukemia sequence 1
(BCL2-related) | Prosurvival | 1q21 | BCL2L3, Mcl-1 | | BCL2A1 | BCL2-related protein A1 | Prosurvival | 15q24.3 | ACC-1, ACC-2,
BCL2L5, BFL1, GRS | | BAX | BCL2-associated X protein | Proapoptotic
multidomain | 19q13.3-q13.4 | BCL2L4 | | BOK | BCL2-related ovarian killer | Proapoptotic
multidomain | 2q37.3 | BCL2L9, BOKL, MGC4631 | | BAK1 | BCL2-antagonist/killer 1 | Proapoptotic
multidomain | 6p21.31 | BAK, BCL2L7 | | BAD | BCL2-associated agonist of cell death | Proapoptotic
BH3-only | 11q13.1 | BBC2, BCL2L8 | | BID | BH3 interacting domain death agonist | Proapoptotic
BH3-only | 22q11.2 | — | | BCL2L11 | BCL2-like 11
(apoptosis facilitator) | Proapoptotic
BH3-only | 2q13 | BIM, BimEL, BimL,
BimS, BOD | | BMF | BCL2 modifying factor | Proapoptotic
BH3-only | 15q14 | FLJ00065 | | BIK | BCL2-interacting killer (apoptosis-inducing) | Proapoptotic
BH3-only | 22q13.31 | NBK | | HRK | Harakiri, BCL2 interacting protein | Proapoptotic
BH3-only | 12q24.2 | DP5 | | PMAIP1 | Phorbol-12-myristate-13-acetate-induced protein 1 | Proapoptotic
BH3-only | 18q21.32 | APR, NOXA | | BBC3 | BCL2 binding component 3 | Proapoptotic
BH3-only | 19q13.3-q13.4 | JFY1, PUMA |
|
|
